North China Pharmaceutical completes redemption of short-term financing notes

North China Pharmaceutical Co., Ltd. announced the successful completion of the redemption for its first tranche of short-term commercial paper for 2025. The company had issued these short-term financing notes, totaling 500 million yuan, on May 16, 2025. The notes carried an interest rate of 1.86% and a maturity period of 180 days.

The redemption date was scheduled for November 15, 2025. As of November 17, 2025, North China Pharmaceutical confirmed it had completed the redemption, with the principal and interest totaling 504,586,301.37 yuan.

Further details regarding the issuance were previously disclosed on the Shanghai Stock Exchange website on May 20, 2025, under announcement number 2025-026.